KAUSHIK J DAVE
CIK 1522751 · CEO and Interim CFO · last filed 2017-03-16
KAUSHIK J DAVE is a CEO and Interim CFO who has filed 12 SEC Form 4 insider transactions across 3 companies since 2011. The most recent filing, for ATNM, was dated Mar 16, 2017. Across all open-market trades the lifetime net is −$220.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $14.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.88M
3
12
-$220.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATNM | CEO and Interim CFO | 88,500 | $1.01 | $89.4K | $20.2K | 4 | 2017-03-16 |
| ANTARES PHARMA, INC. (ATRS) Delisted | Executive Vice President | 313,028 | $5.59 | $1.75M | -$240.8K | 4 | 2013-06-05 |
| AIS | Executive Vice President | 192,594 | $76.82 | $14.80M | $0 | 3 | 2012-05-21 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-03-16 | ATNM | Grant (A) | — | $0 | EDGAR |
| 2016-04-18 | ATNM | Mixed | +10,000 | $20.2K | EDGAR |
| 2015-05-22 | ATNM | Mixed | −156,084 | -$382.4K | EDGAR |
| 2015-03-16 | ATNM | Grant (A) | — | $0 | EDGAR |
| 2013-12-24 | — | Grant (A) | — | $0 | |
| 2013-06-05 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | — | -$170.0K | EDGAR |
| 2013-05-24 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | +58,922 | $0 | EDGAR |
| 2013-05-08 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | — | -$42.6K | EDGAR |
| 2012-07-10 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | +21,127 | $0 | EDGAR |
| 2012-05-21 | AIS | Grant (A) | — | $0 | EDGAR |